Mechanisms of Neural Cell Death: Implications for Development of Neuroprotective Treatment Strategies

NeuroRx

Volumn 1, Issue 1, 2004, Pages 5-16

  Yakovlev, Alexander G ^a   Faden, Alan I ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AIF; Apoptosis; calpain; caspase; necrosis

Indexed keywords

ALOXISTATIN ACID; AM 36; CA 074; CALPAIN; CASPASE; CASPASE 3; CATHEPSIN; DEXANABINOL; ENDONUCLEASE G; ENZYME INHIBITOR; PROTIRELIN; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CELL DEATH; ENZYME ACTIVATION; HUMAN; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PROTEIN SYNTHESIS; ANIMAL; BRAIN; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; BRAIN; CELL DEATH; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS;

EID: 13544251757     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.1.1.5     Document Type: Article

References (130)

1. Eldadah B., and Faden A. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma 17 (2000) 811-829
2. Snider B., Gottron F., and Choi D. Apoptosis and necrosis in cerebrovascular disease. Ann NY Acad Sci 893 (1999) 243-253
3. Graeber M., and Moran L. Mechanisms of cell death in neurodegenerative diseases: fashion, fiction, and facts. Brain Pathol 12 (2002) 385-390
4. Honig L., and Rosenberg R. Apoptosis and neurologic disease. Am J Med 108 (2000) 317-330
5. Panter S., and Faden A. Biochemical changes and secondary injury from stroke and trauma. In: Young R., and Delwade P. (Eds). Principles and practice of restorative neurology (1992), Butterworth's, New York 32-52 chap 5
6. McIntosh T. Neurochemical sequelae of traumatic brain injury: therapeutic implications. Cerebrovasc Brain Metab Rev 6 (1994) 109-162
7. Pohl D., Bittigau P., Ishimaru M., Stadthaus D., Hubner C., Olney J., et al. N-methyl-d-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 96 (1999) 2508-2513
8. Faden A. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol 78 (1996) 12-17
9. Pitts L., Ross A., Chase G., and Faden A. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 12 (1995) 235-243
10. Bracken M., and Holford T. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2. J Neurosurg 79 (1993) 500-507
11. Faden A. Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol 15 (2002) 707-712
12. Lees K. Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view. Stroke 33 (2002) 308-309
13. Schweichel J., and Merker H. The morphology of various types of cell death in prenatal tissues. Teratology 7 (1973) 253-266
14. Kerr J., Wyllie A., and Currie A. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
15. Kitanaka C., and Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 6 (1999) 508-515
16. Clarke P. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 181 (1990) 195-213
17. Van Cruchten S., and Van Den Broeck W. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 31 (2002) 214-223
18. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8 (2001) 569-581
19. Bredesen D. Neural apoptosis. Ann Neurol 38 (1995) 839-851
20. Levin S., Bucci T., Cohen S., Fix A., Hardisty J., LeGrand E., et al. The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol Pathol 27 (1999) 484-490
21. Formigli L., Papucci L., Tani A., Schiavone N., Tempestini A., Orlandini G., et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 182 (2000) 41-49
22. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92 (1995) 7162-7166
23. Eguchi Y., Shimizu S., and Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57 (1997) 1835-1840
24. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G., and Davies S. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci USA 97 (2000) 8093-8097
25. Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17 (2000) 843-855
26. Dal Canto M., and Gurney M. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145 (1994) 1271-1279
27. Sperandio S., de Belle I., and Bredesen D. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97 (2000) 14376-14381
28. Castro-Obregon S., Del Rio G., Chen S., Swanson R., Frankowski H., Rao R., et al. A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ 9 (2002) 807-817
29. Ravagnan L., Roumier T., and Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol 192 (2002) 131-137
30. Hengartner M. Programmed cell death in the nematode C. elegans. Recent Prog Horm Res 54 (1999) 213-222
31. Alnemri E., Livingston D., Nicholson D., Salvesen G., Thornberry N., Wong W., et al. Human ICE/ced-3 protease nomenclature [letter]. Cell 87 (1996) 171
32. Ethell D., Bossy-Wetzel E., and Bredesen D. Caspase 7 can cleave tumor necrosis factor receptor-I (p60) at a non-consensus motif, in vitro. Biochim Biophys Acta 1541 (2001) 231-238
33. Cohen G. Caspases: the executioners of apoptosis. Biochem J 326 (1997) 1-16
34. Kuida K., Zheng T., Na S., Kuan C., Yang D., Karasuyama H., et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384 (1996) 368-372
35. Yakovlev A., and Faden A. Caspase-dependent apoptotic pathways in CNS injury. Mol Neurobiol 24 (2001) 131-144
36. Aravind L., Dixit V., and Koonin E. The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci 24 (1999) 47-53
37. Slee E., Harte M., Kluck R., Wolf B., Casiano C., Newmeyer D., et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144 (1999) 281-292
38. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
39. Cory S., and Adams J. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2 (2002) 647-656
40. Yakovlev A., Ota K., Wang G., Movsesyan V., Bao W., Yoshihara K., et al. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 21 (2001) 7439-7446
41. Kuida K., Haydar T., Kuan C., Gu Y., Taya C., Karasuyama H., et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94 (1998) 325-337
42. Gonzalez-Garcia M., Perez-Ballestero R., Ding L., Duan L., Boise L., Thompson C., et al. Bcl-XL is the major Bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120 (1994) 3033-3042
43. Motoyama N., Wang F., Roth K., Sawa H., Nakayama K., Negishi I., et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267 (1995) 1506-1510
44. Moriishi K., Huang D., Cory S., and Adams J. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc Natl Acad Sci USA 96 (1999) 9683-9688
45. Hausmann G., O'Reilly L., van Driel R., Beaumont J., Strasser A., Adams J., et al. Pro-apoptotic apoptosis protease-activating factor 1 (Apaf-1) has a cytoplasmic localization distinct from Bcl-2 or Bcl-x(L). J Cell Biol 149 (2000) 623-634
46. Shimizu S., Konishi A., Kodama T., and Tsujimoto Y. Bh4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death [Erratum 1;97:9347, 2000]. Proc Natl Acad Sci USA 97 (2000) 3100-3105
47. Fujita N., Nagahashi A., Nagashima K., Rokudai S., and Tsuruo T. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene 17 (1998) 1295-1304
48. Hsu Y., Wolter K., and Youle R. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA 94 (1997) 3668-3672
49. Gross A., Jockel J., Wei M., and Korsmeyer S. Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17 (1998) 3878-3885
50. Shindler K., Latham C., and Roth K. Bax deficiency prevents the increased cell death of immature neurons in bcl-x-deficient mice. J Neurosci 17 (1997) 3112-3119
51. Scorrano L., Oakes S., Opferman J., Cheng E., Sorcinelli M., Pozzan T., et al. Bax and Bak regulation of endoplasmic reticulum CA2+: a control point for apoptosis. Science 300 (2003) 135-139
52. Bossy-Wetzel E., and Green D. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274 (1999) 17484-17490
53. Lassus P., Opitz-Araya X., and Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297 (2002) 1352-1354
54. Guo Y., Srinivasula S., Druilhe A., Fernandes-Alnemri T., and Alnemri E. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277 (2002) 13430-13437
55. Schuler M., Bossy-Wetzel E., Goldstein J., Fitzgerald P., and Green D. P53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275 (2000) 7337-7342
56. Minn A., Boise L., and Thompson C. Bcl-x(S) antagonizes the protective effects of Bcl-x(L). J Biol Chem 271 (1996) 6306-6312
57. Srinivasula S., Ahmad M., Guo Y., Zhan Y., Lazebnik Y., Fernandes-Alnemri T., et al. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res 59 (1999) 999-1002
58. Benedict M., Hu Y., Inohara N., and Nunez G. Expression and functional analysis of Apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J Biol Chem 275 (2000) 8461-8468
59. Jiang Z., and Wu J. Alternative splicing and programmed cell death. Proc Soc Exp Biol Med 220 (1999) 64-72
60. Cardone M., Roy N., Stennicke H., Salvesen G., Franke T., Stanbridge E., et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
61. Fujita E., Jinbo A., Matuzaki H., Konishi H., Kikkawa U., and Momoi T. Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem Biophys Res Commun 264 (1999) 550-555
62. Zhou H., Li X., Meinkoth J., and Pittman R. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol 151 (2000) 483-494
63. Datta S., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
64. Wang H., Pathan N., Ethell I., Krajewski S., Yamaguchi Y., Shibasaki F., et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284 (1999) 339-343
65. Ayllon V., Martinez A., Garcia A., Cayla X., and Rebollo A. Protein phosphatase 1α is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J 19 (2000) 2237-2246
66. Yang E., Zha J., Jockel J., Boise L., Thompson C., and Korsmeyer S. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80 (1995) 285-291
67. Francois F., and Grimes M. Phosphorylation-dependent Akt cleavage in neural cell in vitro reconstitution of apoptosis. J Neurochem 73 (1999) 1773-1776
68. Hay B. Understanding IAP function and regulation: a view from drosophila. Cell Death Differ 7 (2000) 1045-1056
69. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
70. Hegde R., Srinivasula S., Zhang Z., Wassell R., Mukattash R., Cilenti L., et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 277 (2002) 432-438
71. Deveraux Q., and Reed J. IAP family proteins-suppressors of apoptosis. Genes Dev 13 (1999) 239-252
72. Takahashi R., Deveraux Q., Tamm I., Welsh K., Assa-Munt N., Salvesen G., et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273 (1998) 7787-7790
73. Deveraux Q., Roy N., Stennicke H., Van Arsdale T., Zhou Q., Srinivasula S., et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17 (1998) 2215-2223
74. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8 (2001) 613-621
75. Jiang X., Kim H., Shu H., Zhao Y., Zhang H., Kofron J., et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299 (2003) 223-226
76. Matilla A., Koshy B., Cummings C., Isobe T., Orr H., and Zoghbi H. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389 (1997) 974-978
77. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S., Kumar V., et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J 19 (2000) 4310-4322
78. Beere H., Wolf B., Cain K., Mosser D., Mahboubi A., Kuwana T., et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2 (2000) 469-475
79. Bruey J., Ducasse C., Bonniaud P., Ravagnan L., Susin S., Diaz-Latoud C., et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2 (2000) 645-652
80. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
81. Bitko V., and Barik S. An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem 80 (2001) 441-454
82. Nakagawa T., and Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150 (2000) 887-894
83. Wang S., Miura M., Jung Y., Zhu H., Li E., and Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92 (1998) 501-509
84. Kang S., Wang S., Hara H., Peterson E., Namura S., Amin-Hanjani S., et al. Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol 149 (2000) 613-622
85. Schotte P., Van Criekinge W., Van de Craen M., Van Loo G., Desmedt M., Grooten J., et al. Cathepsin B-mediated activation of the proinflammatory caspase-11. Biochem Biophys Res Commun 251 (1998) 379-387
86. Yamashima T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 62 (2000) 273-295
87. Troy C., Stefanis L., Greene L., and Shelanski M. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation, in sympathetic neurons and PC12 cells. J Neurosci 17 (1997) 1911-1918
88. Bergeron L., Perez G., Macdonald G., Shi L., Sun Y., Jurisicova A., et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12 (1998) 1304-1314
89. Adelson P., and Kochanek P. Head injury in children. J Child Neurol 13 (1998) 2-15
90. de Bilbao F., Guarin E., Nef P., Vallet P., Giannakopoulos P., and Dubois-Dauphin M. Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridization study. J Comp Neurol 409 (1999) 339-357
91. Hu B., Liu C., Ouyang Y., Blomgren K., and Siesjo B. Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20 (2000) 1294-1300
92. van Loo G., Saelens X., van Gurp M., MacFarlane M., Martin S., and Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9 (2002) 1031-1042
93. Volbracht C., Leist M., Kolb S., and Nicotera P. Apoptosis in caspase-inhibited neurons. Mol Med 7 (2001) 36-48
94. Zhan R., Wu C., Fujihara H., Taga K., Qi S., Naito M., et al. Both caspase-dependent and caspase-independent pathways may be involved in hippocampal CA1 neuronal death because of loss of cytochrome c from mitochondria in a rat forebrain ischemia model. J Cereb Blood Flow Metab 21 (2001) 529-540
95. Oppenheim R., Flavell R., Vinsant S., Prevette D., Kuan C., and Rakic P. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J Neurosci 21 (2001) 4752-4760
96. Daugas E., Susin S., Zamzami N., Ferri K., Irinopoulou T., Larochette N., et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14 (2000) 729-739
97. Loeffler M., Daugas E., Susin S., Zamzami N., Metivier D., Nieminen A., et al. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 15 (2001) 758-767
98. Susin S., Lorenzo H., Zamzami N., Marzo I., Snow B., Brothers G., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
99. Ravagnan L., Gurbuxani S., Susin S., Maisse C., Daugas E., Zamzami N., et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 3 (2001) 839-843
100. Klein J., Longo-Guess C., Rossmann M., Seburn K., Hurd R., Frankel W., et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 (2002) 367-374
101. Zhang X., Chen J., Graham S., Du L., Kochanek P., Draviam R., et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem 82 (2002) 181-191
102. Cote J., and Ruiz-Carrillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science 261 (1993) 765-769
103. Li L., Luo X., and Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412 (2001) 95-99
104. Liu X., Zou H., Slaughter C., and Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89 (1997) 175-184
105. van Loo G., Schotte P., van Gurp M., Demol H., Hoorelbeke B., Gevaert K., et al. Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 8 (2001) 1136-1142
106. Widlak P., Li L., Wang X., and Garrard W. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J Biol Chem 276 (2001) 48404-48409
107. Srinivasula S., Datta P., Fan X., Fernandes-Alnemri T., Huang Z., and Alnemri E. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol Chem 275 (2000) 36152-36157
108. Roberts D., Merrison W., MacFarlane M., and Cohen G. The inhibitor of apoptosis protein-binding domain of Smac is not essential for its proapoptotic activity. J Cell Biol 153 (2001) 221-228
109. Shibata M., Hattori H., Sasaki T., Gotoh J., Hamada J., and Fukuuchi Y. Subcellular localization of a promoter and an inhibitor of apoptosis (Smac/DIABLO and XIAP) during brain ischemia/reperfusion. Neuroreport 13 (2002) 1985-1988
110. Okada H., Suh W., Jin J., Woo M., Du C., Elia A., et al. Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 22 (2002) 3509-3517
111. Syntichaki P., and Tavernarakis N. Death by necrosis. Uncontrollable catastrophe, or is there order behind the chaos?. EMBO Rep 3 (2002) 604-609
112. Proskuryakov S., Konoplyannikov A., and Gabai V. Necrosis: a specific form of programmed cell death?. Exp Cell Res 283 (2003) 1-16
113. Kitanaka C., and Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Tanpakushitsu Kakusan Koso 44 (1999) 2091-2100
114. Syntichaki P., Xu K., Driscoll M., and Tavernarakis N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419 (2002) 939-944
115. Saido T., Sorimachi H., and Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8 (1994) 814-822
116. Bartus R., Hayward N., Elliott P., Sawyer S., Baker K., Dean R., et al. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration. Stroke 25 (1994) 2265-2270
117. Kampfl A., Posmantur R., Zhao X., Schmutzhard E., Clifton G., and Hayes R. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update. J Neurotrauma 14 (1997) 121-134
118. Saito K., Elce J., Hamos J., and Nixon R. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 90 (1993) 2628-2632
119. Yoshida M., Yamashima T., Zhao L., Tsuchiya K., Kohda Y., Tonchev A., et al. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol (Berl) 104 (2002) 267-272
120. Nakamura Y., Takeda M., Suzuki H., Morita H., Tada K., Hariguchi S., et al. Age-dependent change in activities of lysosomal enzymes in rat brain. Mech Ageing Dev 50 (1989) 215-225
121. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene 12 (1996) 2045-2050
122. Maas A. Neuroprotective agents in traumatic brain injury. Expert Opin Investig Drugs 10 (2001) 753-767
123. Allen J., Knoblach S., and Faden A. Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis. FASEB J 13 (1999) 1875-1882
124. Faden A., Fox G., Fan L., Araldi G., Qiao L., Wang S., et al. Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents. Am J Physiol (Lond) 277 (1999) R1196-R1204
125. Faden A. Pharmacotherapeutic treatment approaches for brain and spinal cord trauma. In: Narayan R., Wilberger J., and Povlishock J. (Eds). Neurotrauma (1996), McGraw-Hill, New York 1479-1490
126. Lavie G., Teichner A., Shohami E., Ovadia H., and Leker R. Long-term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia. Brain Res 901 (2001) 195-201
127. Callaway J., Beart P., Jarrott B., and Giardina S. Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis. Br J Pharmacol 132 (2001) 1691-1698
128. Callaway J., Knight M., Watkins D., Beart P., and Jarrott B. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke 30 (1999) 2704-2712
129. Faden A., Fox G., Di X., Knoblach S., Cernak I., Mullins P., et al. Neuroprotective and nootropic actions of a novel cyclized dipeptide following controlled cortical impact injury in mice. J Cereb Blood Flow Metab 23 (2003) 355-363
130. Faden A., Knoblach S., Cernak I., Fan L., Vink R., Roth B., et al. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro. J Cereb Blood Flow Metab 23 (2003) 342-354